Literature DB >> 11996484

Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil.

E Van Cutsem, P M Hoff, J L Blum, M Abt, B Osterwalder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11996484     DOI： 10.1093/annonc/mdf108

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  34 in total

1.  Simultaneous neoadjuvant radiochemotherapy with capecitabine and oxaliplatin for locally advanced rectal cancer. Treatment outcome outside clinical trials.

Authors:  J Winkler; L Zipp; J Knoblich; F Zimmermann
Journal:  Strahlenther Onkol       Date:  2012-03-10       Impact factor: 3.621

Review 2.  Cardio-oncology/onco-cardiology.

Authors:  Robert A Hong; Takeshi Iimura; Kenneth N Sumida; Robert M Eager
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

3.  Treatment of advanced colorectal cancer in a patient with cardiotoxic reactions to 5-fluorouracil and capecitabine using suboptimal doses.

Authors:  Joseph H Cioffi; Derek J Estes; Vaia Florou; Bach Ardalan
Journal:  BMJ Case Rep       Date:  2017-11-27

Review 4.  Ischemic Heart Disease: Special Considerations in Cardio-Oncology.

Authors:  Dana Elena Giza; Fernando Boccalandro; Juan Lopez-Mattei; Gloria Iliescu; Kaveh Karimzad; Peter Kim; Cezar Iliescu
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-05

Review 5.  Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.

Authors:  Hui-Ming Chang; Rohit Moudgil; Tiziano Scarabelli; Tochukwu M Okwuosa; Edward T H Yeh
Journal:  J Am Coll Cardiol       Date:  2017-11-14       Impact factor: 24.094

Review 6.  Out of the frying pan and into the fire: damage-associated molecular patterns and cardiovascular toxicity following cancer therapy.

Authors:  Nicole S Klee; Cameron G McCarthy; Patricia Martinez-Quinones; R Clinton Webb
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-09-15

7.  Rapidly developing heart failure from capecitabine cardiotoxicity: a case study.

Authors:  Paurush Ambesh; Kaveh Zivari; Chukwudi Obiagwu; Vijay Shetty; Stephan Kamholz; Gerald Hollander; Jacob Shani
Journal:  Br J Clin Pharmacol       Date:  2018-02-09       Impact factor: 4.335

8.  Capecitabine-induced cardiotoxicity: case report and review of the literature.

Authors:  C Ang; M Kornbluth; M P Thirlwell; R D Rajan
Journal:  Curr Oncol       Date:  2010-02       Impact factor: 3.677

9.  Acute coronary syndrome associated with continuous 5-Fluorouracil infusion in a patient with metastatic colorectal cancer-a case report with a discussion on this clinical dilemma.

Authors:  Carlos Eduardo Paiva; Bianca Sakamoto Ribeiro Paiva; Rodrigo Garita; Odair Carlito Michelin; Katashi Okoshi
Journal:  J Gastrointest Cancer       Date:  2009

10.  Reversible cardiogenic shock following 5-fluorouracil infusion.

Authors:  Charles Ferté; Carlos Gomez Roca; Yohann Loriot; Rastislav Bahleda; Cristian Moldovan; Ariel Cohen; Hassan Izzedine; Jean-Charles Soria; Stephane Ederhy
Journal:  Invest New Drugs       Date:  2009-06-05       Impact factor: 3.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.